File			Country		ages: range, mean ± SD				males	females
GSE13214_family.soft	Brazil		clinic-pathological AD: 69-99			1	8
					pathological/preclinical AD: 72-87		1	3
					Control: 57-94					4	6		
GSE29378_family.soft	USA		control: 81.7 ± 6.9				11	5
					AD:77.3 ± 9.1					9	8	
GSE39420_family.soft	Spain		44-69, 50 ± 1.7					15	6
GSE46579_family.soft	Germany		control: 67.1 ± 7.5				11	11
					AD:72.7 ± 10.4					53	53
GSE48350_family.soft	USA		control: 20-99					26	29
					AD:74-95, 85.7 ± 6.3				11	16
GSE53890_family.soft	USA		AD: 62-100					16	19
GSE26972_family.soft	Israel		control: 73					0	3
					AD: 76.5					0	3
GSE29680_family.soft	Sweden 		AD patients with n-3 FA oil:54-82, 71		6	5
					AD patients with n-3 FA oil: 56-80, 66		3	2
GSE32645_family.soft	Austria  	AD Braak VI: 60-89				0	5
					AD Braak V: 86					0	1
					AD Braak IV: 79-92				0	3
					AD Braak III: 66				0	1
					Control: 30-97					6	11
GSE34879_family.soft	USA		Sporadic AD: 83					1	1
					Familial AD: 46 & 53				1	1
					control: 86					2	0
GSE36980_family.soft	Japan		AD: 105-83					7	9
					non-AD: 54-100					10	13
GSE46131_family.soft	USA		University of Kentucky Brain Bank
						Control: 75 & 85			0	2
						AD: 67-86				0	5
					Douglas Montreal Brain Bank				
						Control: 57-89				6	2
						AD: 66-92				5	6
GSE48552_family.soft	Netherlands 	Cohort 1
						Control: 41-92				14	9
						AD: 55-96				14	27
					Cohort 2
						Non-demented control Braak 0-3: 64-93	13	14
						AD Braak 4-6: 58-88			10	11
					Cohort 3
						AD: 77-86				8	0
						Non-demented control:71-96		8	0
GSE59685_family.soft	Brain Banks    London Cohort 
                        			Quantitative Braak Analysis 
						    Braak 0-2: 77.6±12.80        	13    16 
						    Braak 3-4: 88.5±5.20        	7    11 
						    Braak 5-6: 85.5±8.00        	26    40 
						Case-Control Analysis for blood 
						    Control: 80.0±6.14        		15    16 
						    AD: 86.6±7.53            		20    40 
					    Mount Sinai Cohort: Quantitative Braak/Amyloid Analysis 
						Braak 0-2: 82.1±7.56            	31    28 
						Braak 3-4: 89.0±6.48            	11    30 
						Braak 5-6: 88.00±7.53            	12    32 
					    Oxford Cohort: Quantitative Braak Analysis 
						Braak 0-2: 82.6±9.16			10    12 
						Braak 5-6: 75.8±8.75            	15    24 
GSE63060_family.soft	USA		Batch 1
						Control: 70.2±3.7			23	41
						AD: 69.8±4.4				15	34
GSE63061_family.soft	UK		Batch 2
GSE63063_family.soft				Control: 70.8±2.9			27	44
						AD: 69.9±4.3				17	23